Calcium Administration in Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

818

Participants

Timeline

Start Date

January 14, 2019

Primary Completion Date

July 13, 2025

Study Completion Date

August 13, 2025

Conditions
Cardiac SurgeryCardiopulmonary Bypass
Interventions
DRUG

Calcium Chloride

Calcium Chloride

DRUG

0.9% Sodium Chloride

0.9% Sodium Chloride

Trial Locations (11)

630055

Meshalkin Research Institute of Pathology of Circulation, Novosibirsk

Unknown

Sh. Mohammed Bin Khalifa Bin Salman Al-Khalifa Cardiac Center, Manama

Federal Center for Cardiovascular Surgery, Astrakhan

Federal Center for Cardiovascular Surgery, Chelyabinsk

District clinical hospital, Khanty-Mansiysk

B.V. Petrovsky Russian Scientific Surgery Center, Moscow

M. Vladimirsky Moscow Regional Research Cinical Institute (MONIKI), Moscow

Federal Center for Cardiovascular Surgery, Penza

St Petersburg University Multifunctional Clinical Centre, Saint Petersburg

Tomsk National Research Medical Center, Tomsk

King Abdullah Medical City, Mecca

All Listed Sponsors
collaborator

Università Vita-Salute San Raffaele

OTHER

lead

Meshalkin Research Institute of Pathology of Circulation

NETWORK

NCT03772990 - Calcium Administration in Cardiac Surgery | Biotech Hunter | Biotech Hunter